CSPX vs INRKAAD: fund overlap
ETF comparisons / CSPX vs INRKAAD
iShares VII Public Limited Company - iShares S&P 500 - B UCITS ETF (Acc) compared with Sparinvest Mix Maksimum Risiko KL A
CSPX and INRKAAD overlap by 32.3% by weight, across 356 shared companies.
iShares VII Public Limited Company - iShares S&P 500 - B UCITS ETF (Acc)
Sparinvest Mix Maksimum Risiko KL A
Both lines rebased to 0% over their shared dates
356 companies held in both funds
| Shared company | CSPX | INRKAAD |
|---|---|---|
| NVIDIA CORP NVDA | 8.23% | 4.21% |
| Apple Inc AAPL | 7.29% | 3.15% |
| AMAZON.COM INC AMZN | 3.82% | 2.13% |
| Microsoft Corp MSFT | 5.89% | 1.45% |
| BROADCOM INC AVGO | 2.55% | 1.25% |
| ADVANCED MICRO DEVICES AMD | 1.47% | 0.82% |
| ELI LILLY & CO LLY | 1.40% | 0.75% |
| JPMorgan Chase & Co JPM | 1.31% | 0.73% |
| Micron Technology Inc MU | 1.73% | 0.70% |
| Visa Inc V | 0.98% | 0.62% |
| TESLA INC TSLA | 1.60% | 0.61% |
| GE VERNOVA INC. GEV | 0.40% | 0.43% |
| Wells Fargo & Co WFC | 0.38% | 0.46% |
| JOHNSON & JOHNSON JNJ | 0.94% | 0.37% |
| MORGAN STANLEY MS | 0.34% | 0.39% |
| THE PROCTER & GAMBLE COMPANY PG | 0.52% | 0.33% |
| CITIGROUP INC. C | 0.32% | 0.73% |
| THE GOLDMAN SACHS GROUP, INC. GS | 0.39% | 0.28% |
| QUALCOMM Inc QCOM | 0.28% | 0.38% |
| Mastercard Inc MA | 0.71% | 0.28% |
| Gilead Sciences Inc GILD | 0.28% | 0.27% |
| Pfizer Inc PFE | 0.24% | 0.42% |
| AT&T Inc T | 0.23% | 0.52% |
| Caterpillar Inc CAT | 0.55% | 0.23% |
| Applied Materials Inc AMAT | 0.60% | 0.22% |
Based on the holdings compared above
CSPX and INRKAAD overlap by 32.3% by weight, across 356 shared companies.
The largest companies held in both funds are NVIDIA CORP, Apple Inc, AMAZON.COM INC, Microsoft Corp, BROADCOM INC.
Holding both means 32.3% of that part of your portfolio is the same companies counted twice. That can suit you or not depending on your goals; this tool reports the overlap rather than giving advice.
CSPX has a 0.07% expense ratio and INRKAAD has 1.71%.
CSPX has a weighted P/E of 27.0 and INRKAAD has a weighted P/E of 22.7.
See the companies and duplicated exposure across every fund you hold.